Apollomics to Participate in a Fireside Chat at the B. Riley Securities' 2024 Virtual Oncology Conference -January 17, 2024 at 04:31 pm EST
FOSTER CITY, Calif., Jan. 17, 2024 -- Apollomics Inc. , a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Guo-Liang Yu,...